Get it on Google Play

Enanta Pharma (ENTA) Announces Positive Topline Results from First-in-Pediatrics Phase 2 Study

December 9, 2024 6:32 AM EST Send to a Friend
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for virology and immunology indications ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login